iproniazid has been researched along with Acute Liver Injury, Drug-Induced in 37 studies
Excerpt | Relevance | Reference |
---|---|---|
"Drug-induced autoimmune diseases have two immunological peculiarities." | 2.37 | [Autoimmunity induced by drugs. Immunological characteristics and etiopathogenic hypotheses]. ( Homberg, JC, 1984) |
" We proposed a systematic classification scheme using FDA-approved drug labeling to assess the DILI potential of drugs, which yielded a benchmark dataset with 287 drugs representing a wide range of therapeutic categories and daily dosage amounts." | 1.37 | FDA-approved drug labeling for the study of drug-induced liver injury. ( Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V, 2011) |
" An understanding of structure-activity relationships (SARs) of chemicals can make a significant contribution to the identification of potential toxic effects early in the drug development process and aid in avoiding such problems." | 1.36 | Developing structure-activity relationships for the prediction of hepatotoxicity. ( Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (56.76) | 18.7374 |
1990's | 4 (10.81) | 18.2507 |
2000's | 1 (2.70) | 29.6817 |
2010's | 11 (29.73) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fourches, D | 1 |
Barnes, JC | 1 |
Day, NC | 1 |
Bradley, P | 1 |
Reed, JZ | 1 |
Tropsha, A | 1 |
Greene, N | 1 |
Fisk, L | 1 |
Naven, RT | 1 |
Note, RR | 1 |
Patel, ML | 1 |
Pelletier, DJ | 1 |
Morgan, RE | 2 |
Trauner, M | 1 |
van Staden, CJ | 2 |
Lee, PH | 1 |
Ramachandran, B | 1 |
Eschenberg, M | 1 |
Afshari, CA | 2 |
Qualls, CW | 1 |
Lightfoot-Dunn, R | 1 |
Hamadeh, HK | 2 |
Ekins, S | 1 |
Williams, AJ | 1 |
Xu, JJ | 1 |
Chen, M | 2 |
Vijay, V | 1 |
Shi, Q | 2 |
Liu, Z | 2 |
Fang, H | 2 |
Tong, W | 3 |
Dawson, S | 1 |
Stahl, S | 2 |
Paul, N | 1 |
Barber, J | 1 |
Kenna, JG | 2 |
Ding, D | 1 |
Kelly, R | 1 |
Sakatis, MZ | 1 |
Reese, MJ | 1 |
Harrell, AW | 1 |
Taylor, MA | 1 |
Baines, IA | 1 |
Chen, L | 1 |
Bloomer, JC | 1 |
Yang, EY | 1 |
Ellens, HM | 1 |
Ambroso, JL | 1 |
Lovatt, CA | 1 |
Ayrton, AD | 1 |
Clarke, SE | 1 |
Warner, DJ | 1 |
Chen, H | 1 |
Cantin, LD | 1 |
Walker, CL | 1 |
Noeske, T | 1 |
Chen, Y | 1 |
Kalyanaraman, N | 1 |
Kalanzi, J | 1 |
Dunn, RT | 1 |
Suzuki, A | 1 |
Thakkar, S | 1 |
Yu, K | 1 |
Hu, C | 1 |
BERNSTEIN, A | 1 |
SIMON, F | 1 |
SCHALM, L | 1 |
SAPHIER, E | 1 |
COOK, GC | 1 |
SHERLOCK, S | 1 |
WOROBEC, T | 1 |
Rubio Barbón, S | 1 |
León Durán, D | 1 |
Arias Miranda, I | 1 |
Homberg, JC | 4 |
Danan, G | 1 |
Bernuau, J | 2 |
Roche-Sicot, J | 1 |
Pessayre, D | 2 |
Stelly, N | 1 |
Andreis, I | 1 |
Abuaf, N | 1 |
Saadoun, F | 1 |
Andre, J | 1 |
Valerdiz Casasola, S | 1 |
Linares Rodríguez, A | 1 |
Recarte Alvarez, J | 1 |
Rodrigo Sáez, L | 1 |
Capron, JP | 1 |
Gineston, JL | 1 |
Opolon, P | 1 |
Dupas, JL | 1 |
Denis, J | 1 |
Quénum, C | 1 |
Lorriaux, A | 1 |
Matsuki, Y | 1 |
Bandou, R | 1 |
Kiwada, H | 1 |
Maeda, H | 1 |
Goromaru, T | 1 |
Pons, C | 1 |
Dansette, PM | 1 |
Gregeois, J | 1 |
Billett, EE | 1 |
Mansuy, D | 1 |
Maille, F | 1 |
Duvoux, C | 1 |
Cherqui, D | 1 |
Radier, C | 1 |
Zafrani, ES | 1 |
Dhumeaux, D | 1 |
Nelson, SD | 1 |
Mitchell, JR | 2 |
Timbrell, JA | 2 |
Snodgrass, WR | 2 |
Corcoran, GB | 1 |
de Saint-Louvent, P | 1 |
Degott, C | 1 |
Rueff, B | 1 |
Benhamou, JP | 1 |
Gillette, JR | 1 |
Gollini, C | 1 |
Dallari, R | 1 |
Cervi, F | 1 |
Mengoli, M | 1 |
Schläppi, B | 1 |
Ruckebusch, Y | 1 |
Grivel, ML | 1 |
Lajeunesse, BS | 1 |
Babior, BM | 1 |
Davidson, CS | 1 |
Zimmerman, HJ | 2 |
Bondar', ZA | 1 |
Podymova, SD | 1 |
4 reviews available for iproniazid and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Pr | 2016 |
[Autoimmunity induced by drugs. Immunological characteristics and etiopathogenic hypotheses].
Topics: Animals; Autoimmune Diseases; Cardiac Glycosides; Chemical and Drug Induced Liver Injury; Drug Combi | 1984 |
The role of metabolism in the hepatotoxicity of isoniazid and iproniazid.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cobalt; Humans; Hydrazines; Iproniazid; Isoniazid; | 1979 |
[Drug-induced hepatitis].
Topics: Adult; Anti-Bacterial Agents; Antimetabolites; Chemical and Drug Induced Liver Injury; Contraceptive | 1970 |
33 other studies available for iproniazid and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLI | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Des | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2013 |
Chlorpromazine and iproniazid toxic hepatitis in the same patient.
Topics: Chemical and Drug Induced Liver Injury; Chlorpromazine; Hepatitis; Hepatitis A; Iproniazid; Niacin; | 1959 |
[LIVER DAMAGE BY DRUGS].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Arsphenamine; Chemical and Drug Induced Liver Injury; Chl | 1963 |
ANTIDEPRESSANT DRUGS AND LIVER DAMAGE.
Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Chlorpromazine; Hepatitis; Hepatitis | 1964 |
JAUNDICE AND ITS RELATION TO THERAPEUTIC AGENTS.
Topics: Alkaline Phosphatase; Antidepressive Agents; Aspartate Aminotransferases; Bilirubin; Chemical and Dr | 1965 |
BLOOD DYSCRASIAS ASSOCIATED WITH ANTITUBERCULOSIS AND/OR TRANQUILIZING CHEMOTHERAPY. A LONG-TERM CLINICAL OBSERVATION.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Chemical and Drug Induced Liver In | 1965 |
[Antidepressant-induced toxic hepatitis].
Topics: Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Iproniazid; Monoamine Oxidase Inhibit | 2008 |
[Iproniazid-induced hepatitis. The diagnostic value of a new antimitochondrial antibody anti-M6].
Topics: Adult; Antibodies; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; Female; Humans | 1983 |
A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis.
Topics: Adult; Aged; Animals; Autoantibodies; Chemical and Drug Induced Liver Injury; Female; Fluorescent An | 1982 |
[Hepatitis caused by drugs. 4].
Topics: Adult; Aminosalicylic Acid; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Halothane | 1982 |
[Iproniazid-prochlorperazine fulminant hepatitis (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Chemical and Drug Induced Liver Injury; Drug Therapy, Combination; | 1980 |
Effects of ascorbic acid on iproniazid-induced hepatitis in phenobarbital-treated rats.
Topics: Alanine Transaminase; Aminopyrine; Animals; Ascorbic Acid; Aspartate Aminotransferases; Chemical and | 1994 |
Human anti-mitochondria autoantibodies appearing in iproniazid-induced immunoallergic hepatitis recognize human liver monoamine oxidase B.
Topics: Antibody Specificity; Antigen-Antibody Reactions; Autoantibodies; Chemical and Drug Induced Liver In | 1996 |
[Auxiliary hepatic transplantation in iproniazid-induced subfulminant hepatitis. Should iproniazid still be sold in France?].
Topics: Adult; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Female; Follow-Up Studies; Hum | 1999 |
Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat.
Topics: Animals; Chemical and Drug Induced Liver Injury; Humans; Hydrazines; Iproniazid; Isoniazid; Microsom | 1976 |
Iproclozide fulminant hepatitis. Possible role of enzyme induction.
Topics: Adult; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry; Consciousness Disorder | 1978 |
The role of biotransformation in chemical-induced liver injury.
Topics: Acetaminophen; Animals; Biotransformation; Bromobenzenes; Chemical and Drug Induced Liver Injury; Cr | 1976 |
[Iproniazid-induced acute hepatitis].
Topics: Acute Disease; Adult; Chemical and Drug Induced Liver Injury; Humans; Iproniazid; Male; Prognosis | 1992 |
The lack of hepatotoxicity in the rat with the new and reversible MAO-A inhibitor moclobemide in contrast to iproniazid.
Topics: Animals; Benzamides; Body Weight; Chemical and Drug Induced Liver Injury; Iproniazid; Liver; Male; M | 1985 |
[Hepatic insufficiency and neurotropic medicinal activity].
Topics: Animals; Chemical and Drug Induced Liver Injury; Dogs; Drug Synergism; Female; Hexobarbital; Ipronia | 1966 |
[True and false adverse effects of thymoanaleptic medications].
Topics: Amitriptyline; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Depressio | 1968 |
Hepatitis: drug or viral?
Topics: Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Halothane; Hepatitis A; Humans; Ipr | 1966 |
The spectrum of hepatotoxicity.
Topics: Aminosalicylic Acids; Anti-Bacterial Agents; Antimetabolites; Benzene Derivatives; Carbon Tetrachlor | 1968 |
Toxic hepatopathy.
Topics: Aminosalicylic Acids; Anabolic Agents; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Arseni | 1968 |